Product Licenses and Acquisitions (Details Narrative) - USD ($)	3 Months Ended	6 Months Ended
Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Amortization expense	$ 16,000	$ 16,000	$ 32,000	$ 44,000
Natesto
Amortization expense	300,000	300,000	659,000	659,000
Contingent consideration accretion expense	54,000	16,000	133,000	31,000
ZolpiMist
Amortization expense	116,000	116,000	232,000	232,000
Contingent consideration accretion expense	56,000	61,000	110,000	120,000
Tuzistra XR
Amortization expense	123,000	82,000	246,000	82,000
Contingent consideration accretion expense	$ 101,000	$ 46,000	$ 197,000	$ 46,000

The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Name:	us-gaap_DepreciationAndAmortization
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration